cs.LGNov 11, 2026

Binding Mode Matters: Hotspot-Aware Drug Discovery via Explorative Preferences

Authors: Dingshuo Chen, Hao Yang, Kuangqi Zhou, Zhixun Li, Qiang Liu, Xiangxiang Zeng, Shu Wu, Yaosen Min

Organizations: Institute of Automation, Chinese Academy of Sciences · School of Artificial Intelligence, University of Chinese Academy of Sciences · Zhongguancun Academy & Zhongguancun Institute of Artificial Intelligence · Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University · 

Abstract

Discovering hit molecules requires not just high binding affinity, but also the identification of diverse binding modes, which are critical for experimental assays. Existing generative approaches have predominantly relied on optimizing a scalar docking score, obscuring the distinct contributions of key binding determinants. To this end, we introduce a paradigm shift by formulating target-based drug design as a multi-objective exploration task, where each objective explicitly corresponds to enhancing interactions with a specific hotspot. Here, we introduce BindMol, a novel generative framework driven by a customized multi-objective reinforcement learning algorithm. By incorporating explorative preferences during training, our approach efficiently uncovers molecules with diverse and desirable binding profiles. Empirical results demonstrate that BindMol facilitates the discovery of high-affinity compounds characterized by both structural novelty and diverse binding modes. Validated across target-based drug discovery and multi-property optimization tasks, our approach provides a versatile paradigm for goal-oriented drug discovery.

Figures & tables

Appendix figures & tables11 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

CardsList
  1. DBMol: Design of High-Affinity, Target-Specific Small Molecules through Structure Prediction Models

    Jul 21, 2026Yiming Qin, Kai Yi, Miruna Cretu +3Protein-Ligand Binding Affinity PredictionMolecular Optimization

  2. DrugGen 2: A disease-aware language model for enhancing drug discovery

    Jul 9, 2026Ali Motahharynia, Mohammadreza Ghaffarzadeh-Esfahani, Mahsa Sheikholeslami +4Molecular GenerationConditional Generative Modeling

  3. ToolMol: Evolutionary Agentic Framework for Multi-objective Drug Discovery

    May 12, 2026Andrew Y. Zhou, Sharvaree Vadgama, Sumanth Varambally +3Drug DiscoveryAI Agents for Scientific Discovery